Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial.
Ji N, Mukherjee N, Morales EE, Tomasini ME, Hurez V, Curiel TJ, Abate G, Hoft DF, Zhao XR, Gelfond J, Maiti S, Cooper LJN, Svatek RS.
eCollection 2019. PubMed PMID: 31413921; PubMed Central PMCID: PMC6682354.
https://www.ncbi.nlm.nih.gov/pubmed/31413921